Interventional Cardiology Devices Market Report Scope & Overview:
Interventional Cardiology Devices Market Size was valued at USD 22.23 billion in 2024 and is expected to reach USD 37.29 billion by 2032, growing at a CAGR of 6.68% over the forecast period.
The global Interventional Cardiology Devices Market is growing, as people age, the risk for developing cardiovascular diseases, including coronary artery disease, heart failure, and the aging process of the cardiovascular system, including stiffened arteries and the narrowing of blood vessels, also increases. Heart-related illnesses are particularly common in those aged 65 and older, making them ideal TAVR candidates. This has led to an increasing need for minimally invasive, catheter-based therapies with shorter recovery times and lower procedural risk.
For instance, in February 2025, according to the WHO, Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year.
Key Interventional Cardiology Devices Market Trends
-
Growing adoption of minimally invasive PCI and peripheral interventions for faster recovery and reduced hospital stays.
-
Drug-eluting and bioresorbable stents dominate innovation, improving safety and long-term outcomes.
-
Embolic protection and atherectomy devices are increasingly used in complex and high-risk interventions.
-
Rising prevalence of CAD and PAD globally, especially in aging and diabetic populations, is fueling procedure volumes.
-
Expansion of cardiac cath labs in Asia-Pacific and Latin America to meet rising interventional cardiology demand.
-
Shift toward precision-guided, imaging-assisted, and robotic interventions for safer, more efficient procedures.
Interventional Cardiology Devices Market Report Highlights
The U.S. interventional cardiology devices market size was valued at USD 5.69 billion in 2024 and is projected to reach USD 9.38 billion by 2032, growing at a CAGR of 6.46% over the analysis period 2025-2032. The US is the leading market in the global interventional cardiology devices market, with a large number of patients suffering from cardiovascular diseases and a huge demand for minimally invasive technologies in their treatment in the region. The presence of leading device manufacturers and ongoing R&D expenditures also contribute to the U.S. dominance, being able to sustain a high level of pace of innovation, high procedure volume, and market share.
Us image
Interventional cardiology devices market trends are attributed to escalating burden of cardiovascular diseases, growing utilization of minimally invasive and transcatheter cardiovascular procedures, rapid uptake of next-generation imaging technologies, and continuous technological advancements, underpinned by enhancement in global healthcare infrastructure and affirmative reimbursement policies.
Key Interventional Cardiology Devices Market Segment Analysis
-
By Product, Coronary stents held the largest share of around 35.32% in 2024, and the structural heart devices segment is expected to register the highest growth with a CAGR of 7.41%.
-
By Procedure Type, the PCI segment dominated the market with approximately 55.76% share in 2024, while PVI is expected to register the highest growth with a CAGR of 7.33%.
-
By Technology, drug-eluting accounted for the leading share of nearly 60.52% in 2024, whereas biodegradable is expected to register the highest growth with a CAGR of 7.75%.
-
By End User, the Hospitals & ASCs segment led the market with about 60.22% share in 2024, and is forecasted to grow the fastest at a CAGR of 6.85%.
By Product, Coronary Stents Lead Market and Structural Heart Devices Register Fastest Growth
In 2024, the coronary stents segment held a demanding revenue of around 35.32% in the interventional cardiology devices market share and is expected to continue its dominance, owing to their large application in PCI, the great power of inhibiting restenosis, and the huge acceptance of drug-eluting stents. Increasing incidence of cardiovascular diseases, advancements in technology, and rising demand for minimally invasive procedures contribute to the dominance of this segment in the market. The structural heart devices segment is projected to experience the fastest CAGR growth of around 7.41%, due to increasing uptake of TAVR and MitraClip, growing aging-valve population, demand for less invasive modalities, and technological advancements enhancing patient outcomes and procedural safety.
By Procedure Type, Interventional Cardiology Dominates and Shows Rapid Growth Over the Forecast Period
The interventional cardiology devices industry was dominated by the percutaneous coronary intervention (PCI) segment with a revenue share of over 55.76% in 2024, driven by its efficacy for coronary artery disease, high global volumes, and high usage of stents and balloons. Growing cardiovascular load, inclination towards minimal invasive procedures, and ongoing device developments are among the key factors fuelling the dominance. On the peripheral vascular intervention (PVI) hand, it is anticipated to record the fastest CAGR of 7.33% during the forecast period (2024-2032), due to increasing peripheral artery disease population, diabetes, and geriatric population, increasing penetration of minimally invasive procedures, advanced stents, and improving healthcare facilities globally.
By Technology, Drug-Eluting Lead, Whereas It Registers the Fastest Growth
The drug-eluting segment led the interventional cardiology devices industry with the highest revenue market share of about 60.52% in 2024, owing to its demonstrable potential for lowering rates of restenosis and enhancing long-term results. Their successful use in the context of percutaneous coronary intervention (PCI), strong adoption, and ongoing development of drug-polymer combinations. The biodegradable segment is likely to register the fastest CAGR of approximately 7.75% over the forecast years 2024-2032, due to greater use of provisional scaffolding, bioresorbable material progress, and lower long-term complications, together with a growing clinical confidence in safer novelty temporary metallic stent alternatives in the field of interventional cardiology.
By End User, Hospitals & ASCs Lead, and Grow the Fastest
The hospitals & clinics segment of the interventional cardiology devices industry was estimated as the highest earning segment with a revenue share of around 60.22% in 2024, owing to developed healthcare infrastructure, trained cardiologists, a large number of procedures, a favorable reimbursement scenario, and the adoption of integrated imaging devices to expedite patient care and lead the market. And projected to attain the highest CAGR of approximately 6.85% throughout the forecast period (2024-2032), owing to the growing number of outpatient cardiac procedures, growing adoption of ASCs, introduction of minimally invasive procedures, and the rising number of cath lab installations and increasing healthcare expenditure in emerging countries.
Asia Pacific Interventional Cardiology Devices Market Insights
The Asia Pacific segment is projected to witness the fastest CAGR of 7.07% during the forecast period of 2024–2032, as there is an increasing prevalence of cardiovascular diseases, a geriatric population, and the incidence of diabetes and obesity. Increased healthcare infrastructure, government initiatives, and growing awareness regarding minimally invasive cardiac procedures further boost the adoption. Moreover, the growing spending by global device manufacturers, favourable reimbursement policies, and rapid expansion of catheterization labs in countries including China, India, and Japan further bolster the regional outlook.
North America Interventional Cardiology Devices Market Insights
North America accounted for the highest revenue share of approximately 38.80% in 2024 of the interventional cardiology devices Market, owing to the well-established medical facilities, high incidence of CVDs, and heavy uptake of non-invasive techniques, comprising connections among PCI and TAVR. The presence of top global device manufacturers, huge R&D investments, and robust reimbursement systems will add to the market leadership. Furthermore, the strong awareness, presence of experienced cardiologists, and easy accessibility to advanced cardiac centers have further ensured that North America continues to lead the market.
Europe Interventional Cardiology Devices Market Insights
The Europe Interventional Cardiology Devices Market is growing steadily due to the increasing incidence of cardiovascular diseases, the growing geriatric population, and high penetration of minimally invasive procedures, including PCI and structural heart procedures. The market is driven by robust healthcare infrastructure, positive reimbursement policies, and established R&D efforts by key device manufacturers. Moreover, increased awareness, a rising number of cardiac centers, and early adoption of advanced technologies, including bioresorbable and drug-eluting stents, are also contributing to the large market share of Europe.
Latin America (LATAM) and Middle East & Africa (MEA) Interventional Cardiology Devices Market Insights
The Middle East & Africa and Latin America markets are also increasing, owing to a higher risk of cardiovascular diseases, favorable government healthcare reforms, along with a growing number of low- and middle-income countries (LMICs) with a growing number of cardiac centers in the regions. The Middle East & Africa are a growing market, with a healthy cardiovascular disease patient pool, healthcare investments, a rise in dedicated cardiac centers, and greater use of PCI, TAVR, and other interventional devices.
Interventional Cardiology Devices Market Growth Drivers:
-
Rising Prevalence of Cardiovascular Diseases is Driving the Interventional Cardiology Devices Market Growth
Rise in awareness of animal health is also one of the key factors for the growth of the Interventional Cardiology Devices Market. Growth in pet owners’ concern regarding healthy nutrition, weight monitoring, and pets' well-being is driving the demand for automated feeders. With accurate portion control, purring schedules, and any monitoring, they are designed to allow owners to take care of their pets' health and obesity while also sharing their diets.
For instance, in April 2025, the increasing elderly population globally, especially in North America, Europe, and the Asia-Pacific, drives higher demand for interventional cardiology procedures.
Interventional Cardiology Devices Market Restraints:
-
Stringent Regulatory Approvals are Hampering the Interventional Cardiology Devices Market Growth
The Interventional Cardiology Devices Market is heavily dependent on the regularity clearance of the products, and due to its complex and time-consuming process across countries, the market faces some challenges to handle. For devices including drug-eluting stents (DES), bioresorbable scaffolds, and structural heart implants, extensive clinical trials and regulatory approval by the FDA, EMA, PMDA, among others, are required, which may cause long launch waits, high development costs, and market unavailability on time.
Interventional Cardiology Devices Market Opportunities:
-
Emerging Markets Expansion is a Significant Growth Opportunity in the Interventional Cardiology Devices Market
The use of AI and machine learning in Interventional Cardiology Devices offers major potential, improving diagnostic accuracy, predictive analytics, and workflow. The firms’ institutions and care centers will gain an edge over competitors when they choose AI-driven imaging, as control over the Interventional Cardiology Devices Market affects profit margins and hastens technology upgrades globally.
For instance, in March 2025Top of Form, rising cardiovascular disease and expanding cardiac centers in the Asia-Pacific are driving increased adoption of interventional cardiology procedures.
Competitive Landscape for Interventional Cardiology Devices Market:
Boston Scientific Corporation (est. 1979, Massachusetts, USA): A global leader in coronary and peripheral stents, balloons, and structural heart devices, with a focus on innovative solutions for minimally invasive heart and vascular interventions.
-
In February 2025, Boston Scientific launched the SYNERGY XD drug-eluting stent in Europe and expanded TAVR/MitraClip structural heart devices in the Asia-Pacific, enhancing coronary and minimally invasive procedure outcomes.
Medtronic plc (est. 1949, USA, Minnesota) Multi-national medical device company that designs, manufactures, and sells coronary and peripheral stents, guidewires, and catheter systems for endovascular therapy, and other cardiovascular devices, including heart valve systems.
-
In March 2025, Medtronic introduced the IN. PACT Admiral drug-coated balloon in the U.S. and expanded robotic-assisted PCI systems across Europe and Latin America for precise cardiovascular interventions.
Abbott Laboratories (est. 1888, Illinois, USA) Integrated healthcare company, focused on drug-eluting stents, vascular closure systems, and diagnostics, with leadership positions in interventional cardiology, and a commitment to continued innovation in the market.
-
In January 2025, Abbott Laboratories received FDA approval for the XIENCE Skypoint DES for complex coronary lesions and launched new coronary and peripheral devices in emerging markets, improving global interventional cardiology access.
Interventional Cardiology Devices Market Key Players:
Some of the Interventional Cardiology Devices Market Companies
-
Boston Scientific Corporation
-
Medtronic plc
-
Abbott Laboratories
-
Edwards Lifesciences Corporation
-
Terumo Corporation
-
Siemens Healthineers
-
Philips Healthcare
-
Johnson & Johnson
-
Cook Medical
-
Becton Dickinson
-
Cardinal Health
-
MicroPort Scientific Corporation
-
LivaNova PLC
-
Merit Medical Systems, Inc.
-
Sorin Group
-
ABIOMED, Inc.
-
Terumo Interventional Systems
-
Claret Medical, Inc.
-
Neovasc Inc.
-
Boston Scientific
| Report Attributes | Details |
|---|---|
| Market Size in 2024 | USD 22.23 billion |
| Market Size by 2032 | USD 37.29 billion |
| CAGR | CAGR of 6.68% From 2025 to 2032 |
| Base Year | 2024 |
| Forecast Period | 2025-2032 |
| Historical Data | 2021-2023 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments |
• By Product (Coronary Stents, Structural Heart Devices, Angioplasty Balloons, Catheters, Embolic Protection Devices, PTCA Balloon Catheters, Others) |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, France, UK, Italy, Spain, Poland, Russsia, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia,ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, Egypt, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia Rest of Latin America) |
| Company Profiles | Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, Edwards Lifesciences Corporation, Terumo Corporation, Siemens Healthineers, Philips Healthcare, Johnson & Johnson, Cook Medical, Becton Dickinson, Cardinal Health, MicroPort Scientific Corporation, LivaNova PLC, Merit Medical Systems, Inc., Sorin Group, Terumo Interventional Systems, Claret Medical, Inc., Neovasc Inc., Boston Scientific and other players. |
Table of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2021–2032
2.3 Market Size & Forecast, By Segmentation, 2021–2032
2.3.1 Market Size By Product
2.3.2 Market Size By Procedure Type
2.3.2 Market Size By Technology
2.3.2 Market Size By End User
2.4 Market Share & Bps Analysis By Region, 2024
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Procedure Volume Trends (2020–2032)
4.1.1 Global and regional interventional cardiology procedure volumes (PCI, angioplasty, stenting)
4.1.2 Growth rate comparison: coronary vs peripheral interventions
4.1.3 Elective vs emergency cardiac procedure trends
4.2 Patient Demographics and Utilization (2024)
4.2.1 Age-wise and gender-wise distribution of patients undergoing interventions
4.2.2 Urban vs rural utilization patterns for cardiac devices
4.2.3 Insurance coverage trends for interventional cardiology procedures
4.3 Hospital and Cardiac Center Infrastructure Trends (2020–2024)
4.3.1 Distribution of interventional cardiology facilities: hospital-owned, standalone cardiac centers, corporate chains
4.3.2 Number of new cath labs launched annually by region
4.3.3 Average cath lab capacity, number of ORs, and staff-to-patient ratios
4.4 Reimbursement and Payer Mix Analysis (2024)
4.4.1 Share of interventional cardiology procedures reimbursed by Medicare, Medicaid, private insurance, and out-of-pocket
4.4.2 Reimbursement rate comparison: cath labs vs hospital cardiac units for major procedures
4.4.3 Adoption of bundled payments, value-based care, and device-specific reimbursement policies
4.5 Cost Savings and Device Pricing (2024)
4.5.1 Average cost savings per procedure using minimally invasive devices vs traditional surgery
4.5.2 Price comparison for major devices: stents, balloons, guidewires, and embolic protection systems
4.5.3 Trends in pricing transparency, patient preference, and adoption of lower-cost alternatives
5. Interventional Cardiology Devices Market Segmental Analysis & Forecast, By Product, 2021 – 2032, Value (USD Billion)
5.1 Introduction
5.2 Coronary Stents
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2021 – 2032
5.3 Structural Heart Devices
5.3.1 Key Trends
5.3.2 Market Size & Forecast, 2021 – 2032
5.4 Angioplasty Balloons
5.4.1 Key Trends
5.4.2 Market Size & Forecast, 2021 – 2032
5.5 Catheters
5.5.1 Key Trends
5.5.2 Market Size & Forecast, 2021 – 2032
5.6 Embolic Protection Devices
5.6.1 Key Trends
5.6.2 Market Size & Forecast, 2021 – 2032
5.7 PTCA Balloon Catheters
5.7.1 Key Trends
5.7.2 Market Size & Forecast, 2021 – 2032
5.8 Others
5.8.1 Key Trends
5.8.2 Market Size & Forecast, 2021 – 2032
6. Interventional Cardiology Devices Market Segmental Analysis & Forecast, By Procedure Type, 2021 – 2032, Value (USD Billion)
6.1 Introduction
6.2 Percutaneous Coronary Intervention (PCI)
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2021 – 2032
6.3 Peripheral Vascular Intervention
6.3.1 Key Trends
6.3.2 Market Size & Forecast, 2021 – 2032
6.4 Structural Heart Procedures
6.4.1 Key Trends
6.4.2 Market Size & Forecast, 2021 – 2032
7. Interventional Cardiology Devices Market Segmental Analysis & Forecast, By Technology, 2021 – 2032, Value (USD Billion)
7.1 Introduction
7.2 Drug-Eluting
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2021 – 2032
7.3 Biodegradable
7.3.1 Key Trends
7.3.2 Market Size & Forecast, 2021 – 2032
7.4 Advanced Imaging
7.4.1 Key Trends
7.4.2 Market Size & Forecast, 2021 – 2032
8. Interventional Cardiology Devices Market Segmental Analysis & Forecast, By End User, 2021 – 2032, Value (USD Billion)
8.1 Introduction
8.2 Hospitals & ASCs
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2021 – 2032
8.3 Catheterization Labs & Others
8.3.1 Key Trends
8.3.2 Market Size & Forecast, 2021 – 2032
9. Interventional Cardiology Devices Market Segmental Analysis & Forecast By Region, 2021 – 2025, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.2.3 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.2.4 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.2.5 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.2.6 Interventional Cardiology Devices Market Size & Forecast, By Country, 2021 – 2032
9.2.6.1 USA
9.2.6.1.1 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.2.6.1.2 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.2.6.1.3 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.2.6.1.4 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.2.6.2 Canada
9.2.6.2.1 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.2.6.2.2 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.2.6.2.3 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.2.6.2.4 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.3 Europe
9.3.1 Key Trends
9.3.2 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.3.3 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.3.4 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.3.5 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.3.6 Interventional Cardiology Devices Market Size & Forecast, By Country, 2021 – 2032
9.3.6.1 Germany
9.3.6.1.1 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.3.6.1.2 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.3.6.1.3 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.1.4 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.3.6.2 UK
9.3.6.2.1 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.3.6.2.2 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.3.6.2.3 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.2.4 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.3.6.3 France
9.3.6.3.1 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.3.6.3.2 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.3.6.3.3 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.3.4 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.3.6.4 Italy
9.3.6.4.1 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.3.6.4.2 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.3.6.4.3 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.4.4 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.3.6.5 Spain
9.3.6.5.1 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.3.6.5.2 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.3.6.5.3 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.5.4 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.3.6.6 Russia
9.3.6.6.1 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.3.6.6.2 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.3.6.6.3 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.6.4 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.3.6.7 Poland
9.3.6.7.1 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.3.6.7.2 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.3.6.7.3 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.7.4 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.3.6.8 Rest of Europe
9.3.6.8.1 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.3.6.8.2 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.3.6.8.3 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.8.4 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.4.3 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.4.4 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.4.5 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.4.6 Interventional Cardiology Devices Market Size & Forecast, By Country, 2021 – 2032
9.4.6.1 China
9.4.6.1.1 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.4.6.1.2 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.4.6.1.3 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.4.6.1.4 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.4.6.2 India
9.4.6.2.1 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.4.6.2.2 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.4.6.2.3 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.4.6.2.4 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.4.6.3 Japan
9.4.6.3.1 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.4.6.3.2 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.4.6.3.3 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.4.6.3.4 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.4.6.4 South Korea
9.4.6.4.1 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.4.6.4.2 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.4.6.4.3 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.4.6.4.4 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.4.6.5 Australia
9.4.6.5.1 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.4.6.5.2 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.4.6.5.3 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.4.6.5.4 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.4.6.6 ASEAN Countries
9.4.6.6.1 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.4.6.6.2 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.4.6.6.3 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.4.6.6.4 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.4.6.7 Rest of Asia-Pacific
9.4.6.7.1 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.4.6.7.2 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.4.6.7.3 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.4.6.7.4 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.5 Latin America
9.5.1 Key Trends
9.5.2 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.5.3 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.5.4 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.5.5 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.5.6 Interventional Cardiology Devices Market Size & Forecast, By Country, 2021 – 2032
9.5.6.1 Brazil
9.5.6.1.1 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.5.6.1.2 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.5.6.1.3 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.5.6.1.4 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.5.6.2 Argentina
9.5.6.2.1 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.5.6.2.2 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.5.6.2.3 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.5.6.2.4 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.5.6.3 Mexico
9.5.6.3.1 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.5.6.3.2 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.5.6.3.3 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.5.6.3.4 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.5.6.4 Colombia
9.5.6.4.1 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.5.6.4.2 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.5.6.4.3 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.5.6.4.4 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.5.6.5 Rest of Latin America
9.5.6.5.1 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.5.6.5.2 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.5.6.5.3 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.5.6.5.4 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.6.3 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.6.4 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.6.5 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.6.6 Interventional Cardiology Devices Market Size & Forecast, By Country, 2021 – 2032
9.6.6.1 UAE
9.6.6.1.1 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.6.6.1.2 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.6.6.1.3 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.6.6.1.4 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.6.6.2 Saudi Arabia
9.6.6.2.1 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.6.6.2.2 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.6.6.2.3 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.6.6.2.4 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.6.6.3 Qatar
9.6.6.3.1 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.6.6.3.2 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.6.6.3.3 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.6.6.3.4 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.6.6.4 Egypt
9.6.6.4.1 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.6.6.4.2 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.6.6.4.3 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.6.6.4.4 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.6.6.5 South Africa
9.6.6.5.1 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.6.6.5.2 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.6.6.5.3 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.6.6.5.4 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
9.6.6.6 Rest of Middle East & Africa
9.6.6.6.1 Interventional Cardiology Devices Market Size & Forecast, By Product, 2021 – 2032
9.6.6.6.2 Interventional Cardiology Devices Market Size & Forecast, By Procedure Type, 2021 – 2032
9.6.6.6.3 Interventional Cardiology Devices Market Size & Forecast, By Technology, 2021 – 2032
9.6.6.6.4 Interventional Cardiology Devices Market Size & Forecast, By End User, 2021 – 2032
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2024
10.2.2 Year-Wise Strategies & Development, 2021 – 2025
10.2.3 Number Of Strategies Adopted By Key Players, 2024
10.3 Market Share Analysis, 2024
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6 Key Company Profiles
10.6.1 Boston Scientific Corporation
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 Medtronic plc
10.6.2.1 Company Overview & Snapshot
10.6.2.2 Product/Service Portfolio
10.6.2.3 Key Company Financials
10.6.2.4 SWOT Analysis
10.6.3 Abbott Laboratories
10.6.3.1 Company Overview & Snapshot
10.6.3.2 Product/Service Portfolio
10.6.3.3 Key Company Financials
10.6.3.4 SWOT Analysis
10.6.4 Edwards Lifesciences Corporation
10.6.4.1 Company Overview & Snapshot
10.6.4.2 Product/Service Portfolio
10.6.4.3 Key Company Financials
10.6.4.4 SWOT Analysis
10.6.5 Terumo Corporation
10.6.5.1 Company Overview & Snapshot
10.6.5.2 Product/Service Portfolio
10.6.5.3 Key Company Financials
10.6.5.4 SWOT Analysis
10.6.6 Siemens Healthineers
10.6.6.1 Company Overview & Snapshot
10.6.6.2 Product/Service Portfolio
10.6.6.3 Key Company Financials
10.6.6.4 SWOT Analysis
10.6.7 Philips Healthcare
10.6.7.1 Company Overview & Snapshot
10.6.7.2 Product/Service Portfolio
10.6.7.3 Key Company Financials
10.6.7.4 SWOT Analysis
10.6.8 Johnson & Johnson
10.6.8.1 Company Overview & Snapshot
10.6.8.2 Product/Service Portfolio
10.6.8.3 Key Company Financials
10.6.8.4 SWOT Analysis
10.6.9 Cook Medical
10.6.9.1 Company Overview & Snapshot
10.6.9.2 Product/Service Portfolio
10.6.9.3 Key Company Financials
10.6.9.4 SWOT Analysis
10.6.10 Becton Dickinson
10.6.10.1 Company Overview & Snapshot
10.6.10.2 Product/Service Portfolio
10.6.10.3 Key Company Financials
10.6.10.4 SWOT Analysis
10.6.11 Cardinal Health
10.6.11.1 Company Overview & Snapshot
10.6.11.2 Product/Service Portfolio
10.6.11.3 Key Company Financials
10.6.11.4 SWOT Analysis
10.6.12 MicroPort Scientific Corporation
10.6.12.1 Company Overview & Snapshot
10.6.12.2 Product/Service Portfolio
10.6.12.3 Key Company Financials
10.6.12.4 SWOT Analysis
10.6.13 LivaNova PLC
10.6.13.1 Company Overview & Snapshot
10.6.13.2 Product/Service Portfolio
10.6.13.3 Key Company Financials
10.6.13.4 SWOT Analysis
10.6.14 Merit Medical Systems, Inc.
10.6.14.1 Company Overview & Snapshot
10.6.14.2 Product/Service Portfolio
10.6.14.3 Key Company Financials
10.6.14.4 SWOT Analysis
10.6.15 Sorin Group
10.6.15.1 Company Overview & Snapshot
10.6.15.2 Product/Service Portfolio
10.6.15.3 Key Company Financials
10.6.15.4 SWOT Analysis
10.6.16 ABIOMED, Inc.
10.6.16.1 Company Overview & Snapshot
10.6.16.2 Product/Service Portfolio
10.6.16.3 Key Company Financials
10.6.16.4 SWOT Analysis
10.6.17 Terumo Interventional Systems
10.6.17.1 Company Overview & Snapshot
10.6.17.2 Product/Service Portfolio
10.6.17.3 Key Company Financials
10.6.17.4 SWOT Analysis
10.6.18 Claret Medical, Inc.
10.6.18.1 Company Overview & Snapshot
10.6.18.2 Product/Service Portfolio
10.6.18.3 Key Company Financials
10.6.18.4 SWOT Analysis
10.6.19 Neovasc Inc.
10.6.19.1 Company Overview & Snapshot
10.6.19.2 Product/Service Portfolio
10.6.19.3 Key Company Financials
10.6.19.4 SWOT Analysis
10.6.20 Boston Scientific
10.6.20.1 Company Overview & Snapshot
10.6.20.2 Product/Service Portfolio
10.6.20.3 Key Company Financials
10.6.20.4 SWOT Analysis
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions On Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
Key Segments:
By Product
-
Coronary Stents
-
Structural Heart Devices
-
Angioplasty Balloons
-
Catheters
-
Embolic Protection Devices
-
PTCA Balloon Catheters
-
Others
By Procedure Type
-
Percutaneous Coronary Intervention (PCI)
-
Peripheral Vascular Intervention
-
Structural Heart Procedures
By Technology
-
Drug-Eluting
-
Biodegradable
-
Advanced Imaging
By End User
-
Hospitals & ASCs
-
Catheterization Labs & Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
ASEAN Countries
-
Australia
-
Rest of Asia Pacific
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
Egypt
-
South Africa
-
Rest of Middle East & Africa
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g., Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
